Autoregulation of thromboinflammation on biomaterial surfaces by a multicomponent therapeutic coating

Biomaterials

Volumn 34, Issue 4, 2013, Pages 985-994

  Nilsson, Per H ^a   Ekdahl, Kristina N ^a,b   Magnusson, Peetra U ^b   Qu, Hongchang ^c   Iwata, Hiroo ^d   Ricklin, Daniel ^c   Hong, Jaan ^b   Lambris, John D ^c   Nilsson, Bo ^b   Teramura, Yuji ^b,d  

^a LINNAEUS UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Apyrase; Coagulation; Complement; Factor H binding peptide; Poly(ethylene glycol) (PEG); Surface modification

Indexed keywords

APYRASE; AUTOREGULATIONS; BIOLOGICAL RESPONSE; BIOMATERIAL SURFACES; BLOOD CONTACT; COMPLEMENT; COMPLEMENT SYSTEMS; H-BINDING; HEMOCOMPATIBILITY; HYBRID SURFACE; INNATE IMMUNITY; MODIFIED SURFACES; MULTICOMPONENTS; WHOLE BLOOD;

BIOLOGICAL MATERIALS; BIOMATERIALS; COAGULATION; PEPTIDES; POLYETHYLENE GLYCOLS; SURFACE TREATMENT;

SURFACES;

5C6 PEPTIDE; APYRASE; BIOMATERIAL; COMPLEMENT FACTOR H; MACROGOL; PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; AUTOREGULATION; BIOTINYLATION; ENDOTHELIUM CELL; ERYTHROCYTE; HUMAN; INFLAMMATION; MULTICOMPONENT THERAPEUTIC COATING; PEPTIDE SYNTHESIS; PORCINE AORTIC ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; THROMBOINFLAMMATION;

CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; COMPLEMENT ACTIVATION; ERYTHROCYTES; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MATERIALS TESTING; SURFACE PROPERTIES; THROMBOSIS;

EID: 84870308011     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.10.040     Document Type: Article

References (42)

1. Ratner B.D. The catastrophe revisited: blood compatibility in the 21st Century. Biomaterials 2007, 28:5144-5147.
2. Nilsson B., Korsgren O., Lambris J.D., Ekdahl K.N. Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?. Trends Immunol 2010, 31:32-38.
3. Bennet W., Sundberg B., Groth C.G., Brendel M.D., Brandhorst D., Brandhorst H., et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation?. Diabetes 1999, 48:1907-1914.
4. Moberg L., Johansson H., Lukinius A., Berne C., Foss A., Kallen R., et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002, 360:2039-2045.
5. Gustafson E.K., Elgue G., Hughes R.D., Mitry R.R., Sanchez J., Haglund U., et al. The instant blood-mediated inflammatory reaction characterized in hepatocyte transplantation. Transplantation 2011, 91:632-638.
6. Diepenhorst G.M., van Gulik T.M., Hack C.E. Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann Surg 2009, 249:889-899.
7. Nilsson P.H., Engberg A.E., Back J., Faxalv L., Lindahl T.L., Nilsson B., et al. The creation of an antithrombotic surface by apyrase immobilization. Biomaterials 2010, 31:4484-4491.
8. Wu Y.Q., Qu H., Sfyroera G., Tzekou A., Kay B.K., Nilsson B., et al. Protection of nonself surfaces from complement attack by factor H-binding peptides: implications for therapeutic medicine. J Immunol 2011, 186:4269-4277.
9. Teramura Y., Kaneda Y., Iwata H. Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 2007, 28:4818-4825.
10. Teramura Y., Iwata H. Cell surface modification with polymers for biomedical studies. Soft Matter 2010, 6:1081-1091.
11. Teramura Y., Iwata H. Improvement of graft survival by surface modification with poly(ethylene glycol)-lipid and urokinase in intraportal islet transplantation. Transplantation 2011, 91:271-278.
12. Andersson J., Larsson R., Richter R., Ekdahl K.N., Nilsson B. Binding of a model regulator of complement activation (RCA) to a biomaterial surface: surface-bound factor H inhibits complement activation. Biomaterials 2001, 22:2435-2443.
13. Platts-Mills T.A., Ishizaka K. Activation of the alternate pathway of human complements by rabbit cells. J Immunol 1974, 113:348-358.
14. Nilsson U.R., Nilsson B. Simplified assays of hemolytic activity of the classical and alternative complement pathways. J Immunol Methods 1984, 72:49-59.
15. Luan N.M., Teramura Y., Iwata H. Immobilization of soluble complement receptor 1 on islets. Biomaterials 2011.
16. Hong J., Nilsson Ekdahl K., Reynolds H., Larsson R., Nilsson B. A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin. Biomaterials 1999, 20:603-611.
17. Ekdahl K.N., Nilsson B., Pekna M., Nilsson U.R. Generation of IC3 at the interface between blood and gas. Scand J Immunol 1992, 35:85-91.
18. Jackson R.W., Basinger S.F., Werth J.M. Use of a logistic function in expressing kinetic hemolysis data. Infect Immun 1970, 1:142-145.
19. Hessing M., Vlooswijk R.A., Hackeng T.M., Kanters D., Bouma B.N. The localization of heparin-binding fragments on human C4b-binding protein. J Immunol 1990, 144:204-208.
20. Schmidt C.Q., Herbert A.P., Hocking H.G., Uhrin D., Barlow P.N. Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clin Exp Immunol 2008, 151:14-24.
21. Engberg A.E., Sandholm K., Bexborn F., Persson J., Nilsson B., Lindahl G., et al. Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides. Biomaterials 2009, 30:2653-2659.
22. Nilsson U.R., Storm K.E., Elwing H., Nilsson B. Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface. Mol Immunol 1993, 30:211-219.
23. Andersson J., Ekdahl K.N., Lambris J.D., Nilsson B. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials 2005, 26:1477-1485.
24. Tengvall P., Askendal A., Lundstrom I. Temporal studies on the deposition of complement on human colostrum IgA and serum IgG immobilized on methylated silicon. J Biomed Mater Res 1997, 35:81-92.
25. Andersson J., Ekdahl K.N., Larsson R., Nilsson U.R., Nilsson B. C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase. J Immunol 2002, 168:5786-5791.
26. Murakami Y., Iwata H., Kitano E., Kitamura H., Ikada Y. Interaction of poly(styrene sulfonic acid) with the alternative pathway of the serum complement system. J Biomater Sci Polym Ed 2005, 16:381-395.
27. Andersson J., Bexborn F., Klinth J., Nilsson B., Ekdahl K.N. Surface-attached PEO in the form of activated Pluronic with immobilized factor H reduces both coagulation and complement activation in a whole-blood model. J Biomed Mater Res A 2006, 76:25-34.
28. Wu J., Wu Y.Q., Ricklin D., Janssen B.J., Lambris J.D., Gros P. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat Immunol 2009, 10:728-733.
29. Serruto D., Rappuoli R., Scarselli M., Gros P., van Strijp J.A. Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nat Rev Microbiol 2010, 8:393-399.
30. Markiewski M.M., Nilsson B., Ekdahl K.N., Mollnes T.E., Lambris J.D. Complement and coagulation: strangers or partners in crime?. Trends Immunol 2007, 28:184-192.
31. Hamad O.A., Ekdahl K.N., Nilsson P.H., Andersson J., Magotti P., Lambris J.D., et al. Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets. J Thromb Haemost 2008, 6:1413-1421.
32. Cattaneo M., Gachet C. ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 1999, 19:2281-2285.
33. Marcus A.J., Broekman M.J., Drosopoulos J.H., Islam N., Alyonycheva T.N., Safier L.B., et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997, 99:1351-1360.
34. Eltzschig H.K., Thompson L.F., Karhausen J., Cotta R.J., Ibla J.C., Robson S.C., et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 2004, 104:3986-3992.
35. Grenz A., Osswald H., Eckle T., Yang D., Zhang H., Tran Z.V., et al. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 2008, 5:e137.
36. Reutershan J., Cagnina R.E., Chang D., Linden J., Ley K. Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J Immunol 2007, 179:1254-1263.
37. Van Linden A., Eltzschig H.K. Role of pulmonary adenosine during hypoxia: extracellular generation, signaling and metabolism by surface adenosine deaminase/CD26. Expert Opin Biol Ther 2007, 7:1437-1447.
38. Linden J. Adenosine in tissue protection and tissue regeneration. Mol Pharmacol 2005, 67:1385-1387.
39. Fredholm B. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 2007, 14:1315-1323.
40. Eckle T., Fullbier L., Wehrmann M., Khoury J., Mittelbronn M., Ibla J., et al. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 2007, 178:8127-8137.
41. Volmer J.B., Thompson L.F., Blackburn M.R. Ecto-5'-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. J Immunol 2006, 176:4449-4458.
42. Eltzschig H.K., Ibla J.C., Furuta G.T., Leonard M.O., Jacobson K.A., Enjyoji K., et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 2003, 198:783-796.